🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for Nutraceuticals & Cosmeceuticals

Benchmark revenue and EBITDA valuation multiples for public comps like Zhangzhou Pientzehuang, PharmaResearch, Otsuka Holdings, Abbott India and Dermapharm.

Nutraceuticals & Cosmeceuticals

See analyst estimates and all valuation multiples for Nutraceuticals & Cosmeceuticals
Company EV EV/LTM Revenue EV/LTM EBITDA
$22.9B 1.4x 6.2x
$21.1B 18.4x 57.0x
$16.7B 10.7x 31.7x
$9.4B 3.0x 7.3x
$8.1B 10.7x 39.7x
$6.3B 4.1x 20.9x
$4.2B 13.1x 31.7x
$4.1B 2.0x 13.0x
$3.5B n/a n/a
$3.2B 2.3x 8.5x
$3.0B 1.4x 8.1x
$2.5B 8.3x 16.3x
$1.6B 6.6x 25.2x
$1.6B n/a n/a
$1.3B 2.2x 11.3x
$1.1B 7.7x 27.3x
$1.1B 0.9x 3.8x
$1.0B n/a n/a
$998M n/a n/a
$992M 6.4x 19.5x
$835M 3.4x 8.8x
$708M n/a n/a
$633M 12.2x 34.2x
$627M 1.4x 6.6x
$527M 3.6x 13.6x
$504M n/a n/a
$214M 3.0x n/a
$133M 2.0x 9.3x
$88.9M n/a n/a
$32.5M n/a n/a
$25.1M n/a n/a
$21.4M 0.9x -29.3x
$16.3M 13.8x -1.5x
$13.0M n/a n/a
$8.1M n/a n/a
$4.3M n/a n/a
$2.7M n/a n/a
-$3.2M n/a n/a

Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.

See analyst estimates and M&A multiples for Nutraceuticals & Cosmeceuticals

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.